share_log

普利制药:关于无法在法定期限内披露2023年年度报告及2024年第一季度报告暨公司股票及可转换公司债券停牌的公告

Hainan Poly Pharm: Announcement on the inability to disclose the 2023 Annual Report and the 2024 First Quarter Report and the suspension of trading of company stocks and convertible corporate bonds within the statutory period

Sensex a share ·  Apr 30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more